{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:12Z","timestamp":1786986852618,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.clindermatol.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T11:04:08Z","timestamp":1450523048000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica"],"prefix":"10.1016","volume":"34","author":[{"given":"Karen C.","family":"Broussard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa G.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-David","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2015.11.006_bb0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archderm.1973.01620220022005","article-title":"Cicatricial pemphigoid. Immunofluorescence investigations","volume":"108","author":"Holubar","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0015","doi-asserted-by":"crossref","first-page":"11579","DOI":"10.1073\/pnas.88.24.11579","article-title":"Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0020","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0025","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","article-title":"Antigen specificity in subsets of mucous membrane pemphigoid","volume":"126","author":"Rashid","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0030","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1172\/JCI110333","article-title":"Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium","volume":"68","author":"Anhalt","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/clim.2000.4845","article-title":"Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice","volume":"95","author":"Lazarova","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ophtha.2003.03.001","article-title":"Mucous membrane pemphigoid and pseudopemphigoid","volume":"111","author":"Thorne","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0050","first-page":"191","article-title":"Mucous membrane pemphigoid: Clinical aspects, immunopathological features and therapy","volume":"17","author":"Bruch-Gerharz","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0055","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1365-2133.2008.08753.x","article-title":"Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180","volume":"159","author":"Daito","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0060","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.02.012","article-title":"A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer","volume":"47","author":"Sadler","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0070","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthal Soc"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","article-title":"Immunosuppressive therapy for progressive ocular cicatricial pemphigoid","volume":"89","author":"Foster","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0080","series-title":"Current Therapy in Dermatology","first-page":"56","article-title":"Cicatricial pemphigoid","author":"Jabs","year":"1993"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0190-9622(82)70014-3","article-title":"Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone","volume":"6","author":"Rogers","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2012.10.018","article-title":"Critical analysis of the use of rituximab in mucous membrane pemphigoid: A review of the literature","volume":"68","author":"Shetty","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.preteyeres.2004.05.005","article-title":"Ocular cicatricial pemphigoid: Pathogenesis, diagnosis and treatment","volume":"23","author":"Ahmed","year":"2004","journal-title":"Progress Retinal Eye Res"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003226-199105000-00001","article-title":"Sainz de la Maza M, Foster CS. Systemic chemotherapy for ocular cicatricial pemphigoid","volume":"10","author":"Tauber","year":"1991","journal-title":"Cornea"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0110","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2008.08.002","article-title":"Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy","volume":"115","author":"Thorne","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9394(14)77908-5","article-title":"Immunosuppressive therapy in ocular cicatricial pemphigoid","volume":"96","author":"Mondino","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0135","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ophtha.2003.07.010","article-title":"Methotrexate therapy for ocular cicatricial pemphigoid","volume":"111","author":"McCluskey","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0140","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ophtha.2009.09.049","article-title":"Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: A preliminary report","volume":"117","author":"Foster","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0150","series-title":"Dermatology","first-page":"461","article-title":"Pemphigus","author":"Amagai","year":"2012"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0155","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1073\/pnas.87.19.7658","article-title":"Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris","volume":"87","author":"Ahmed","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0160","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1073\/pnas.88.11.5056","article-title":"Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris","volume":"88","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2002.04564.x","article-title":"Genotyping for HLA-A, B and C alleles in Japanese patients with pemphigus: Prevalence of Asian alleles of the HLA-B15 family","volume":"146","author":"Miyagawa","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/1523-1747.ep12337585","article-title":"HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese","volume":"109","author":"Miyagawa","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0180","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.1983.03330350056029","article-title":"Transplacental transmission of pemphigus","volume":"249","author":"Wasserstrum","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0185","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1172\/JCI5252","article-title":"Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris","volume":"103","author":"Mahoney","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0200","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clindermatol.2011.01.016","article-title":"Drug-induced pemphigus","volume":"29","author":"Brenner","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0210","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2005.02.061","article-title":"Ocular pemphigus","volume":"53","author":"Daoud","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.1990.tb01478.x","article-title":"Conjunctival involvement in pemphigus vulgaris: A clinical, histopathological and immunofluorescence study","volume":"123","author":"Hodak","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.iac.2007.12.002","article-title":"Ocular manifestations of blistering diseases","volume":"28","author":"Elchahal","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004397-199703720-00006","article-title":"Ocular cicatricial pemphigoid and ocular manifestations of pemphigus vulgaris","volume":"37","author":"Smith","year":"1997","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0230","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/OPX.0b013e31821ddef3","article-title":"Conjunctival erosions associated with pemphigus vulgaris","volume":"88","author":"Brackley","year":"2011","journal-title":"Optometry Vision Sci"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/B:INTE.0000031736.69290.18","article-title":"Severe conjunctival and eyelid involvement in pemphigus vulgaris","volume":"25","author":"Lifshitz","year":"2004","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2007.02.046","article-title":"Ocular involvement in pemphigus","volume":"144","author":"Palleschi","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0245","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/09273948.2013.791924","article-title":"An uncommon ocular manifestation of pemphigus vulgaris: Conjunctival mass","volume":"21","author":"Uludag","year":"2013","journal-title":"Ocular Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0250","first-page":"174912","article-title":"Multiple conjunctival papillomas of eyelid margins in pemphigus vulgaris","volume":"2011","author":"Avisar","year":"2011","journal-title":"Case Rep Ophthalmol Med"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0255","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archderm.1984.01650430127024","article-title":"Adjuvant therapy of pemphigus","volume":"120","author":"Bystryn","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0260","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clindermatol.2011.03.014","article-title":"Current therapy of the pemphigus group","volume":"30","author":"Kasperkiewicz","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0265","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0270","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0275","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0280","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0285","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archdermatol.2012.1522","article-title":"Adjuvant rituximab therapy of pemphigus: A single-center experience with 31 patients","volume":"148","author":"Lunardon","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0290","first-page":"383","article-title":"Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity","volume":"8","author":"D'Auria","year":"1997","journal-title":"Eur Cytokine Network"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-1747.2000.00835.x","article-title":"In vitro and in vivo expression of interleukin-1 alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: Interleukin-1 alpha and tumor necrosis factor-alpha are involved in acantholysis","volume":"114","author":"Feliciani","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0300","first-page":"940","article-title":"Successful treatment of pemphigus vulgaris with etanercept in four patients","volume":"8","author":"Shetty","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0305","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/j.jaad.2011.05.029","article-title":"Infliximab therapy failure in two patients with pemphigus vulgaris","volume":"67","author":"Garcia-Rabasco","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archdermatol.2010.409","article-title":"A pilot study of etanercept treatment for pemphigus vulgaris","volume":"147","author":"Fiorentino","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0315","first-page":"365","article-title":"Triamcinolone acetonide for rare ocular manifestations of pemphigus vulgaris: A case report","volume":"4","author":"Kozeis","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0320","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0325","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: A reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0330","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2007.00322.x","article-title":"Paraneoplastic pemphigus","volume":"34","author":"Zhu","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0335","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2133.1998.02056.x","article-title":"Paraneoplastic pemphigus associated with Hodgkin's disease","volume":"138","author":"Dega","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0340","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0345","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2133.2006.07605.x","article-title":"Paraneoplastic pemphigus without an underlying neoplasm","volume":"156","author":"Park","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0350","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0190-9622(99)70145-3","article-title":"The new pemphigus variants","volume":"40","author":"Robinson","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0355","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","article-title":"Paraneoplastic pemphigus in children and adolescents","volume":"147","author":"Mimouni","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0360","first-page":"77","article-title":"Paraneoplastic pemphigus","volume":"12","author":"Anhalt","year":"1997","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0365","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0370","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.det.2011.06.016","article-title":"Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome)","volume":"29","author":"Frew","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0375","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2133.2001.04030.x","article-title":"Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A case report and review of literature","volume":"144","author":"Hsiao","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0380","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0002-9394(14)74494-0","article-title":"Conjunctival involvement in paraneoplastic pemphigus","volume":"114","author":"Meyers","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0385","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0161-6420(92)32030-5","article-title":"Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma","volume":"99","author":"Lam","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0390","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2008.1306","article-title":"Paraneoplastic pemphigus: An uncommon cause of chronic cicatrising conjunctivitis","volume":"2009","author":"Tam","year":"2009","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0395","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000051622","article-title":"Bilateral corneal melting in a patient with paraneoplastic pemphigus","volume":"202","author":"Beele","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0400","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1346-8138.2010.01192.x","article-title":"Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: A case report and review of cases treated with rituximab","volume":"38","author":"Anan","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0405","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1346-8138.12095","article-title":"Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab","volume":"40","author":"Aoi","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0410","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0","article-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","volume":"66","author":"Heizmann","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0415","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ophtha.2009.09.006","article-title":"Paraneoplastic conjunctival cicatrization: Two different pathogenic types","volume":"117","author":"Ahuero","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2015.11.006_bb0420","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2165\/00003495-200565130-00003","article-title":"Autoimmune bullous diseases: Ocular manifestations and management","volume":"65","author":"Laforest","year":"2005","journal-title":"Drugs"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X1500231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X1500231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T15:29:11Z","timestamp":1537111751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X1500231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0738081X1500231X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.006","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}